Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
268 studies found for:    "Cytomegalic inclusion disease"
Show Display Options
Rank Status Study
1 Recruiting MSC for Treatment of CMV Infection
Conditions: Stem Cell Transplantation, Hematopoietic;   CMV Infection;   Hematological Diseases
Intervention: Biological: MSCs
2 Completed Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
Condition: Cytomegalovirus Infections
Intervention: Drug: SDZ MSL-109
3 Completed Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
Conditions: Cytomegalovirus Infections;   HIV Infections
Intervention: Drug: Ganciclovir
4 Completed Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
Conditions: Cytomegalovirus Infections;   Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Ganciclovir
5 Completed A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
Conditions: Cytomegalovirus Infections;   HIV Infections
Intervention: Drug: Ganciclovir
6 Completed Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
Conditions: Cytomegalovirus Infection;   Preterm Infants
Intervention: Procedure: ultrashort heat inactivation
7 Recruiting Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Conditions: Transplantation Infection;   Cytomegalovirus Infection
Interventions: Drug: Everolimus;   Drug: mycophenolic acid
8 Active, not recruiting A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.
Condition: Transplant Recipients With CMV Infection
Intervention: Biological: CMV Infection
9 Not yet recruiting Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
Conditions: Ulcerative Colitis;   Cytomegalovirus Infections
10 Completed Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
Conditions: HIV Infection;   CMV Infection
11 Enrolling by invitation Screening for Congenital Cytomegalovirus Infection in Newborns
Condition: Cytomegalovirus Infections
Intervention: Other: Observation
12 Unknown  The Influence of Chronic CMV Infection on Influenza Vaccine Responses
Conditions: Cytomegalovirus Infections;   Influenza
Intervention: Biological: Fluzone® 2012-2013 Formula
13 Recruiting Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy
Condition: Cytomegalovirus Infections
Intervention: Other: Blood draw and MRI
14 Unknown  Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Condition: Cytomegalovirus Disease
Interventions: Drug: Certican (everolimus) + valganciclovir;   Drug: Valganciclovir
15 Completed Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
Condition: Cytomegalovirus Disease
Interventions: Drug: Valganciclovir;   Biological: CMV hyperimmune globulin
16 Recruiting Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
Condition: Cytomegalovirus Infections
Interventions: Drug: Drug conversion to sirolimus;   Drug: Maintenance of the current regimen
17 Recruiting Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: CMV Infection;   Persistent CMV Viremia
Intervention: Genetic: CMVpp65 Specific T-cells
18 Completed Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection
Conditions: Cytomegalovirus Infection;   Infection
19 Completed Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
Condition: Cytomegalovirus Infection
20 Completed Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
Condition: Cytomegalovirus Infection
Intervention: Drug: Single arm (ganciclovir and valganciclovir)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years